Sanofi Genzyme-Strategy, SWOT and Corporate Finance Report
Sanofi Genzyme-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Sanofi Genzyme (Genzyme), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, Mozobil injection, Taxotere injection concentrate, Thymoglobulin, Thyrogen and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. Genzyme is headquartered in Cambridge, Massachusetts, the US.
- Detailed information on Sanofi Genzyme required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments
- Intelligence on Sanofi Genzyme's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Sanofi Genzyme's business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 5
Sanofi Genzyme: Company Overview 9
Sanofi Genzyme: Overview and Key Facts 9
Sanofi Genzyme: Overview 9
Sanofi Genzyme: Key Facts 9
Sanofi Genzyme: Key Employees 10
Sanofi Genzyme: Key Employee Biographies 12
Sanofi Genzyme: Major Products and Services 14
Sanofi Genzyme: Company History 15
Sanofi Genzyme: Locations and Subsidiaries 21
Sanofi Genzyme: Key Competitors 22
Sanofi Genzyme: Company Analysis 23
Sanofi Genzyme: Business Description 23
Sanofi Genzyme: SWOT Analysis 25
Sanofi Genzyme: SWOT Overview 25
Sanofi Genzyme: Strengths 25
Sanofi Genzyme: Weaknesses 26
Sanofi Genzyme: Opportunities 26
Sanofi Genzyme: Threats 27
Sanofi Genzyme: Corporate Financial Deals Activity 28
Sanofi Genzyme: Financial Deals Overview 28
Sanofi Genzyme: Targets and Partners 29
Sanofi Genzyme: Top Deals 2014-2018YTD 30
Sanofi Genzyme: Mergers and Acquisitions 31
Sanofi Genzyme: Partnership 32
Sanofi Genzyme: Recent Developments 33
Sanofi Genzyme: News and Events Summary 33
Sanofi Genzyme: Contracts 36
Sanofi Genzyme: Market Developments 36
Sanofi Genzyme: Regulatory and Legal Events 38
Sanofi Genzyme: Research & Development 39
Sanofi Genzyme: Strategy and Operations 40
Contact Us 41
About MarketLine 42
List of Figures
Figure 1: Sanofi Genzyme: Deal Activity by Deal Type-Volume (2014-YTD 2018)
Figure 2: Sanofi Genzyme: M&A Average Deal Size-Value (USD m)
Figure 3: Sanofi Genzyme: M&A Volume and Value Trend (2014-YTD 2018)
Figure 4: Sanofi Genzyme: Partnership Volume and Value Trend (2014-YTD 2018)
Figure 5: San
Single User License:
Corporate User License:
select a license
NEWSLETTER BY CATEGORY
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"
An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ... "General Manager SBU Manufacture, PT. KIMIA FARMA, TBK"